Taysha Gene Therapies Inc (TSHA) — Net Asset Momentum
Taysha Gene Therapies Inc (TSHA) recorded a net asset momentum of 245.2% as of December 2025, with net assets of $246.94 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See TSHA net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Taysha Gene Therapies Inc Net Asset Momentum (2019–2025)
This chart tracks Taysha Gene Therapies Inc's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +245.2%, with net assets of $246.94 Million USD as of December 2025. For live market cap and overall valuation, see Taysha Gene Therapies Inc (TSHA) market capitalisation.
Annual Net Asset History for Taysha Gene Therapies Inc (2019–2025)
The table below shows the complete annual net asset history for Taysha Gene Therapies Inc from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Taysha Gene Therapies Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $246.94 Million | $343.32 Million | $96.38 Million | ▲ +245.2% |
| 2024 | $71.53 Million | $160.36 Million | $88.84 Million | ▼ -4.6% |
| 2023 | $74.94 Million | $172.73 Million | $97.79 Million | ▲ +7796.4% |
| 2022 | $949.00K | $126.28 Million | $125.33 Million | ▼ -99.0% |
| 2021 | $95.38 Million | $213.96 Million | $118.57 Million | ▼ -62.0% |
| 2020 | $251.30 Million | $258.88 Million | $7.58 Million | ▲ +186249.6% |
| 2019 | $-135.00K | $15.00K | $150.00K | — |